To investigate the effect of magnesium sulfate combined with ritodrine hydrochloride on maternal and infant outcomes in patients with premature rupture of membranes (PROM), a total of 76 PROM patients admitted to our hospital from July 2021 to July 2022 were selected as the research objects, and they were divided into observation group and experimental group according to the treatment methods of the patients. The observation group consisted of 38 patients who received magnesium sulfate monotherapy, whereas the experimental group received ritodrine hydrochloride in addition to the treatment received by the patients in the observation group. The treatment effects, levels of inflammatory factors, negative emotions, as well as maternal and child outcomes, along with any adverse reactions during the medication, were compared between the two groups. The effective rate of treatment in the observation group was 78.95%, and that in the experimental group was 97.37%. The effective rate in the experimental group was significantly higher than that in the observation group ( P < 0.05). The levels of α and IFN-y were significantly lower than those of the observation group (all, P < 0.05); the SAS scores and SDS scores of the experimental group after treatment were significantly lower than those of the observation group (all, P < 0.05). The observation group showed significantly lower uterine contraction inhibition time and postpartum hemorrhage compared to the observation group, along with significantly higher gestational age extension time (all, P <0.05). In terms of neonatal outcomes, the birth weight, Apgar. The scores were significantly higher than those of the observation group, and the incidence of complications was significantly lower than that of the observation group (all, P < 0.05). The incidence of adverse reactions in the observation group was 21.05%, compared to 23.68% in the experimental group. There was no significant difference in the incidence of adverse reactions between the two groups of patients ( P > 0.05). Magnesium sulfate combined with ritodrine hydrochloride has a significant effect in the treatment of patients with PROM. The application of the combined program can effectively reduce the inflammatory response of patients, regulate the negative emotions of patients, and improve the maternal and infant outcomes of patients. Moreover, the combined program does not increase the risk of adverse reactions in patients, demonstrating its ideal safety in clinical medication.
This study aims to investigate the effect and mechanism of nystose on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). hBMSCs were cultured and divided into 5 groups: a control group that received no treatment, and 4 groups treated with varying concentrations of nystose solution (0.5, 1, 5, and 10 μ g/mL). The proliferation ability of hBMSCs was tested at different culture times and different concentrations of nystose solution using cell counting kit-8 assay. Alizarin red staining was employed to examine ALP expression and calcium nodule formation in hBMSCs. Western blotting and RT-PCR were conducted to analyze the expressions of alkaline phosphatase (ALP) and Runt-related transcription factor 2 (RUNX2), as well as the levels of c-Jun N-terminal Kinase (JNK)/extracellular regulated protein kinases (ERK) pathway genes. Our findings demonstrated that increasing nystose concentration enhanced cell proliferation. Notably, compared to the control group, nystose intervention significantly elevated ALP activity and expression of osteoblast-related genes. Additionally, it was observed that nystose intervention increased phosphorylation levels of JNK1 and ERK1/2. Conversely, inhibition of JNK/ERK pathway activity reduced ALP and RUNX2 expression and calcium nodule formation, thereby inhibiting osteogenic differentiation of hBMSCs. Nystose intervention effectively regulated the osteogenic differentiation ability of hBMSCs through modulation of the JNK/ERK pathway. These results provide evidence supporting the promotion of osteogenic differentiation of hBMSCs by nystose, thus offering a promising therapeutic approach for bone-related diseases such as osteoporosis.
Peritoneal adhesions (PA), commonly occurring complications of wound healing, often lead to various medical issues, including secondary, chronic abdominal pain, small bowel obstruction and infertility. In recent years, the focus has shifted towards employing Polyethylene Glycol (PEG), known for its unique biological properties, to mitigate postoperative peritoneal adhesions. PEG stands out for its anti-adhesion capabilities, demonstrated through its surface non-adhesiveness, ability to inhibit protein adsorption and cell attachment, and its effectiveness in preventing thrombus and fibrin formation, alongside its highly adaptable properties. Consequently, researchers have explored PEGbased materials, often blending or copolymerizing them with other substances to enhance their characteristics. Various adhesion prevention techniques, including membranes, sprays, injectable hydrogels, and solutions, have been extensively studied. This article begins with an exploration of the etiology and complications of peritoneal adhesions, followed by a concise summary of recent advancements in PEG-based anti-adhesion barriers and hydrogels. Additionally, it provides critical insights and comments, laying a theoretical groundwork for future research in this field.
The respiratory system plays a crucial role in human life activities, and acute lung injury (ALI) is a highly fatal respiratory disease caused by a variety of reasons. At present, although several preclinical studies have demonstrated the efficacy of pharmacological interventions, supportive care and mechanical ventilation still remain the primary modalities for managing ALI, there are still no safe and effective treatments for ALI. With the rapid development of nanotechnology, a variety of nanobiomedicines with different structures and functional moieties have been well-designed based on their targeting ability and the pathophysiology of ALI. In this review, it summarizes the challenges faced by ALI therapy, introduces nanobiomedicines including liposomes, polymers, inorganic materials, and others to bring effective therapeutic effects for ALI, and discusses the research progress in recent years based on nanobiomedicine applied to acute lung injury. Finally, it provides a summary and prospect on the application of nanobiomedicine in ALI.
The effects of various contemporary surface conditioning methods, Non-Thermal Plasma (NTP), Rose Bengal photosensitizer (RBPS) activated by low-level laser therapy (LLLT), and Er: YAG laser, on the color change (Δ E ), surface roughness (Ra), and bond strength of Polymer-infiltrated Ceramics (PIC). One hundred discs were fabricated using PIC and categorized into four groups ( n = 15) as follows: Group 1: HFA(S), Group 2: NTP, Group 3: RBPS activated by LLLT, and Group 4: Er: YAG laser. After preparing the surface, five samples from each group were analyzed for color difference (Δ E ) surface roughness (Ra), and SBS. ANOVA was employed to compute the average and standard deviation (SD) of Δ E , Ra, and SBS. Subsequently, post hoc Tukey multiple comparisons were conducted to compare the different groups. The group of samples RBPS triggered by LLLT+HC had the highest Δ E score, while the group of HFA(S)+HC specimens had the lowest ΔE value. The specimens treated with a combination of an Er: YAG laser and HC had the highest Ra score. Collectively, the utilization of HFA+S, NTP, and Er: YAG laser yielded positive results concerning surface roughness and bond strength. Both the RBPS triggered by LLLT and Er: YAG groups exhibited noteworthy changes in the color of the specimens.
